Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
| 适应症 | Heart Failure, Mitral Regurgitation |
|---|---|
| 分期 | 不适用 |
| 申办方 | samir kapadia |
| 状态 | 进行中(已停止招募) |
| 受试者人数 | 16 人 |
| 干预(药物) | V-Wave Shunt Placement |
| 开始日期 | 2021年3月11日 |
| 完成日期 | 2025年1月3日 |
| 结果公布日 | 2026年8月5日 |
摘要
This is an investigator initiated, prospective study to demonstrate the safety and feasibility of implantation of the V-Wave Interatrial Shunt System (herein called the "V-Wave Shunt" in patients immediately following percutaneous mitral valve repair using the MitraClip system.
Number of Occurrence for Device-related Major Adverse Cardiovascular and Neurologic Events (MACNE)
| Treatment | 3 events |
|---|
在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文
同一适应症的其他试验
- Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant — University of Utah
- Mechanism and Effects of Manipulating Chloride Homeostasis in Acute Heart Failure — Yale University
- Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using th — Boston Children's Hospital
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class III — Endotronix, Inc.
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University
- Crome/Cobalt Respiration Study — Medtronic Cardiac Rhythm and Heart Failure